ARTICLE | Company News
CeNeS, Innovata deal
March 13, 2006 8:00 AM UTC
IOV granted CEN rights to IP covering a method of synthetically manufacturing CEN's M6G. The morphine-6-glucoronide (M6G) metabolite of morphine is in Phase III testing for post-operative pain. Finan...